OR WAIT null SECS
May 28, 2015
Experts attending the European Psychiatry Association Congress in Vienna say that Adasuve has made an impact in the treatment of agitation in patients suffering from schizophrenia or biopolar I disorder.
May 27, 2015
Pharmaceutical companies are constantly aiming for shorter drug-development cycles and advances in formulation development produce significant benefits.
This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.
Widespread use and abuse of opioid painkillers is prompting efforts to develop new drugs and formulations that resist abuse while providing relief to legitimate patients.
Eight physician groups wrote to the commissioner of FDA to stress the importance of transparency in biosimilar labeling to decrease prescribing risks.
May 22, 2015
As the biopharma industry awaits FDA’s guidance on biosimilar naming, brand and generic manufacturers establish positions.
May 21, 2015
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 20, 2015
The new guideline replaces the previous version-CHMP/EWP/240/95 Revision 1.
May 19, 2015
Alexion will construct a biologics facility in Ireland that is its first outside the US.
May 15, 2015
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
